Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The daily Top 10 COVID papers

Influenza

Free Subscription Articles published in Proc Natl Acad Sci U S A Retrieve available abstracts of 252 articles: HTML format

Single Articles

February 2021
1. SASISEKHARAN V, Pentakota N, Jayaraman A, Tharakaraman K, et al
   Orthogonal immunoassays for IgG antibodies to SARS-CoV-2 antigens reveal that immune response lasts beyond 4 mo post illness onset.
   Proc Natl Acad Sci U S A. 2021;118.
   PubMed     Abstract available
   
   
   
2. ANDRASFAY T, Goldman N
   Reductions in 2020 US life expectancy due to COVID-19 and the disproportionate impact on the Black and Latino populations.
   Proc Natl Acad Sci U S A. 2021;118.
   PubMed     Abstract available
   
   
   
3. YIANNOUTSOS CT, Halverson PK, Menachemi N
   Bayesian estimation of SARS-CoV-2 prevalence in Indiana by random testing.
   Proc Natl Acad Sci U S A. 2021;118.
   PubMed     Abstract available
   
   
   January 2021
4. HOWARD J, Huang A, Li Z, Tufekci Z, et al
   An evidence review of face masks against COVID-19.
   Proc Natl Acad Sci U S A. 2021;118.
   PubMed     Abstract available
   
   
   
5. MARZIANO V, Guzzetta G, Rondinone BM, Boccuni F, et al
   Retrospective analysis of the Italian exit strategy from COVID-19 lockdown.
   Proc Natl Acad Sci U S A. 2021;118.
   PubMed     Abstract available
   
   
   
6. RAPPUOLI R, De Gregorio E, Del Giudice G, Phogat S, et al
   Vaccinology in the post-COVID-19 era.
   Proc Natl Acad Sci U S A. 2021;118.
   PubMed     Abstract available
   
   
   
7. VOUTOURI C, Nikmaneshi MR, Hardin CC, Patel AB, et al
   In silico dynamics of COVID-19 phenotypes for optimizing clinical management.
   Proc Natl Acad Sci U S A. 2021;118.
   PubMed     Abstract available
   
   
   
8. EVENSEN D, Whitmarsh L, Bartie P, Devine-Wright P, et al
   Effect of "finite pool of worry" and COVID-19 on UK climate change perceptions.
   Proc Natl Acad Sci U S A. 2021;118.
   PubMed     Abstract available
   
   
   
9. PARK SW, Sun K, Champredon D, Li M, et al
   Forward-looking serial intervals correctly link epidemic growth to reproduction numbers.
   Proc Natl Acad Sci U S A. 2021;118.
   PubMed     Abstract available
   
   
   
10. BERENBAUM MR
    On COVID-19, cognitive bias, and open access.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    
    
    
    
11. CHEN MK, Chevalier JA, Long EF
    Nursing home staff networks and COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
12. CARLETON T, Cornetet J, Huybers P, Meng KC, et al
    Global evidence for ultraviolet radiation decreasing COVID-19 growth rates.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
13. CIPPA PE, Cugnata F, Ferrari P, Brombin C, et al
    A data-driven approach to identify risk profiles and protective drugs in COVID-19.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
14. LIU K, Tan S, Niu S, Wang J, et al
    Cross-species recognition of SARS-CoV-2 to bat ACE2.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
15. MUELLER JT, McConnell K, Burow PB, Pofahl K, et al
    Impacts of the COVID-19 pandemic on rural America.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
16. JUNG H, Albarracin D
    Concerns for others increases the likelihood of vaccination against influenza and COVID-19 more in sparsely rather than densely populated areas.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
17. SCHMELZ K
    Enforcement may crowd out voluntary support for COVID-19 policies, especially where trust in government is weak and in a liberal society.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    December 2020
18. SCHLOSSER F, Maier BF, Jack O, Hinrichs D, et al
    COVID-19 lockdown induces disease-mitigating structural changes in mobility networks.
    Proc Natl Acad Sci U S A. 2020;117:32883-32890.
    PubMed     Abstract available
    
    
    
19. MITZE T, Kosfeld R, Rode J, Walde K, et al
    Face masks considerably reduce COVID-19 cases in Germany.
    Proc Natl Acad Sci U S A. 2020;117:32293-32301.
    PubMed     Abstract available
    
    
    
20. WEITZ JS, Park SW, Eksin C, Dushoff J, et al
    Awareness-driven behavior changes can shift the shape of epidemics away from peaks and toward plateaus, shoulders, and oscillations.
    Proc Natl Acad Sci U S A. 2020;117:32764-32771.
    PubMed     Abstract available
    
    
    
21. ZANG R, Case JB, Yutuc E, Ma X, et al
    Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion.
    Proc Natl Acad Sci U S A. 2020;117:32105-32113.
    PubMed     Abstract available
    
    
    
22. TUPPER P, Boury H, Yerlanov M, Colijn C, et al
    Event-specific interventions to minimize COVID-19 transmission.
    Proc Natl Acad Sci U S A. 2020;117:32038-32045.
    PubMed     Abstract available
    
    
    
23. TAYLOR CA, Boulos C, Almond D
    Livestock plants and COVID-19 transmission.
    Proc Natl Acad Sci U S A. 2020;117:31706-31715.
    PubMed     Abstract available
    
    
    
24. WANG Y, Mao Q, Zhou X
    Does tocilizumab have a magical therapeutic effect on COVID-19 patients without obvious adverse reactions?
    Proc Natl Acad Sci U S A. 2020;117:30896-30897.
    PubMed    
    
    
    
25. ZENG HL, Dichio V, Rodriguez Horta E, Thorell K, et al
    Global analysis of more than 50,000 SARS-CoV-2 genomes reveals epistasis between eight viral genes.
    Proc Natl Acad Sci U S A. 2020;117:31519-31526.
    PubMed     Abstract available
    
    
    
26. XU X, Han M, Li T, Sun W, et al
    Reply to Wang et al.: Tocilizumab treatment should be used in a timely manner, at suitable dose, and in suitable patients.
    Proc Natl Acad Sci U S A. 2020;117:30898-30899.
    PubMed    
    
    
    
27. YANG C, Liu E, Liu M
    Safety concerns regarding concomitant use of tocilizumab and glucocorticoids in COVID-19 patients.
    Proc Natl Acad Sci U S A. 2020;117:30025-30026.
    PubMed    
    
    
    
28. XU X, Han M, Li T, Sun W, et al
    Reply to Yang et al.: Tocilizumab treatment in COVID-19 patients needs the assessment of the disease severity and timely intervention.
    Proc Natl Acad Sci U S A. 2020;117:30027-30028.
    PubMed    
    
    
    
29. NISHI A, Dewey G, Endo A, Neman S, et al
    Network interventions for managing the COVID-19 pandemic and sustaining economy.
    Proc Natl Acad Sci U S A. 2020;117:30285-30294.
    PubMed     Abstract available
    
    
    
30. CASADEVALL A, Pirofski LA
    In fatal COVID-19, the immune response can control the virus but kill the patient.
    Proc Natl Acad Sci U S A. 2020;117:30009-30011.
    PubMed    
    
    
    
31. KORTESSIS N, Simon MW, Barfield M, Glass GE, et al
    The interplay of movement and spatiotemporal variation in transmission degrades pandemic control.
    Proc Natl Acad Sci U S A. 2020;117:30104-30106.
    PubMed     Abstract available
    
    
    
32. BAKER RE, Park SW, Yang W, Vecchi GA, et al
    The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infections.
    Proc Natl Acad Sci U S A. 2020;117:30547-30553.
    PubMed     Abstract available
    
    
    
33. BANG A, Khadakkar S
    Opinion: Biodiversity conservation during a global crisis: Consequences and the way forward.
    Proc Natl Acad Sci U S A. 2020;117:29995-29999.
    PubMed    
    
    
    November 2020
34. HORNER C, Schurmann C, Auste A, Ebenig A, et al
    A highly immunogenic and effective measles virus-based Th1-biased COVID-19 vaccine.
    Proc Natl Acad Sci U S A. 2020 Nov 30. pii: 2014468117.
    PubMed     Abstract available
    
    
    
35. SRIRAM K, Loomba R, Insel PA
    Targeting the renin-angiotensin signaling pathway in COVID-19: Unanswered questions, opportunities, and challenges.
    Proc Natl Acad Sci U S A. 2020;117:29274-29282.
    PubMed     Abstract available
    
    
    
36. RELMAN DA
    Opinion: To stop the next pandemic, we need to unravel the origins of COVID-19.
    Proc Natl Acad Sci U S A. 2020;117:29246-29248.
    PubMed    
    
    
    
37. LI W, Chen C, Drelich A, Martinez DR, et al
    Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection.
    Proc Natl Acad Sci U S A. 2020;117:29832-29838.
    PubMed     Abstract available
    
    
    
38. STOKES GL, Lynch AJ, Lowe BS, Funge-Smith S, et al
    COVID-19 pandemic impacts on global inland fisheries.
    Proc Natl Acad Sci U S A. 2020;117:29419-29421.
    PubMed     Abstract available
    
    
    
39. WONG F, Collins JJ
    Evidence that coronavirus superspreading is fat-tailed.
    Proc Natl Acad Sci U S A. 2020;117:29416-29418.
    PubMed     Abstract available
    
    
    
40. SENDER V, Hentrich K, Pathak A, Tan Qian Ler A, et al
    Capillary leakage provides nutrients and antioxidants for rapid pneumococcal proliferation in influenza-infected lower airways.
    Proc Natl Acad Sci U S A. 2020 Nov 23. pii: 2012265117.
    PubMed     Abstract available
    
    
    
41. WESTON S, Baracco L, Keller C, Matthews K, et al
    The SKI complex is a broad-spectrum, host-directed antiviral drug target for coronaviruses, influenza, and filoviruses.
    Proc Natl Acad Sci U S A. 2020 Nov 12. pii: 2012939117.
    PubMed     Abstract available
    
    
    
42. MIORIN L, Kehrer T, Sanchez-Aparicio MT, Zhang K, et al
    SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling.
    Proc Natl Acad Sci U S A. 2020;117:28344-28354.
    PubMed     Abstract available
    
    
    
43. SEITZ BM, Aktipis A, Buss DM, Alcock J, et al
    The pandemic exposes human nature: 10 evolutionary insights.
    Proc Natl Acad Sci U S A. 2020;117:27767-27776.
    PubMed     Abstract available
    
    
    
44. LUMENG JC, Chavous TM, Lok AS, Sen S, et al
    Opinion: A risk-benefit framework for human research during the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2020;117:27749-27753.
    PubMed    
    
    
    
45. POLYAKOVA M, Kocks G, Udalova V, Finkelstein A, et al
    Initial economic damage from the COVID-19 pandemic in the United States is more widespread across ages and geographies than initial mortality impacts.
    Proc Natl Acad Sci U S A. 2020;117:27934-27939.
    PubMed     Abstract available
    
    
    
46. WU M, Chen Y, Xia H, Wang C, et al
    Transcriptional and proteomic insights into the host response in fatal COVID-19 cases.
    Proc Natl Acad Sci U S A. 2020;117:28336-28343.
    PubMed     Abstract available
    
    
    
47. DOLGIN E
    Core Concept: The pandemic is prompting widespread use-and misuse-of real-world data.
    Proc Natl Acad Sci U S A. 2020;117:27754-27758.
    PubMed    
    
    
    
48. XIONG C, Hu S, Yang M, Luo W, et al
    Mobile device data reveal the dynamics in a positive relationship between human mobility and COVID-19 infections.
    Proc Natl Acad Sci U S A. 2020;117:27087-27089.
    PubMed     Abstract available
    
    
    
49. GALASSO V, Pons V, Profeta P, Becher M, et al
    Gender differences in COVID-19 attitudes and behavior: Panel evidence from eight countries.
    Proc Natl Acad Sci U S A. 2020;117:27285-27291.
    PubMed     Abstract available
    
    
    
50. MEROW C, Urban MC
    Seasonality and uncertainty in global COVID-19 growth rates.
    Proc Natl Acad Sci U S A. 2020;117:27456-27464.
    PubMed     Abstract available
    
    
    
51. LI Z, Li X, Huang YY, Wu Y, et al
    Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs.
    Proc Natl Acad Sci U S A. 2020;117:27381-27387.
    PubMed     Abstract available
    
    
    
52. WITTEVEEN D, Velthorst E
    Economic hardship and mental health complaints during COVID-19.
    Proc Natl Acad Sci U S A. 2020;117:27277-27284.
    PubMed     Abstract available
    
    
    
53. RAO L, Xia S, Xu W, Tian R, et al
    Decoy nanoparticles protect against COVID-19 by concurrently adsorbing viruses and inflammatory cytokines.
    Proc Natl Acad Sci U S A. 2020;117:27141-27147.
    PubMed     Abstract available
    
    
    
54. KAMPF G
    Protective effect of mandatory face masks in the public-relevant variables with likely impact on outcome were not considered.
    Proc Natl Acad Sci U S A. 2020;117:27076-27077.
    PubMed    
    
    
    
55. NG QX, De Deyn MLZQ, Yeo WS
    Do face masks help? is not the question.
    Proc Natl Acad Sci U S A. 2020;117:27078-27079.
    PubMed    
    
    
    October 2020
56. KAHN JP, Henry LM, Mastroianni AC, Chen WH, et al
    Opinion: For now, it's unethical to use human challenge studies for SARS-CoV-2 vaccine development.
    Proc Natl Acad Sci U S A. 2020 Oct 29. pii: 2021189117.
    PubMed    
    
    
    
57. SORG RA, Gallay C, Van Maele L, Sirard JC, et al
    Synthetic gene-regulatory networks in the opportunistic human pathogen Streptococcus pneumoniae.
    Proc Natl Acad Sci U S A. 2020 Oct 21. pii: 1920015117.
    PubMed     Abstract available
    
    
    
58. DOWD JB, Block P, Rotondi V, Mills MC, et al
    Dangerous to claim "no clear association" between intergenerational relationships and COVID-19.
    Proc Natl Acad Sci U S A. 2020;117:25975-25976.
    PubMed    
    
    
    
59. ARPINO B, Bordone V, Pasqualini M
    Reply to Dowd et al.: Dangerous to overemphasize the importance of specific COVID-19 risk factors based on (unadjusted) macro-level analyses.
    Proc Natl Acad Sci U S A. 2020;117:25977-25978.
    PubMed    
    
    
    
60. CASTRO M, Ares S, Cuesta JA, Manrubia S, et al
    The turning point and end of an expanding epidemic cannot be precisely forecast.
    Proc Natl Acad Sci U S A. 2020;117:26190-26196.
    PubMed     Abstract available
    
    
    
61. MCDERMOTT A
    Inner Workings: Researchers race to develop in-home testing for COVID-19, a potential game changer.
    Proc Natl Acad Sci U S A. 2020;117:25956-25959.
    PubMed    
    
    
    
62. BOSCO-LAUTH AM, Hartwig AE, Porter SM, Gordy PW, et al
    Experimental infection of domestic dogs and cats with SARS-CoV-2: Pathogenesis, transmission, and response to reexposure in cats.
    Proc Natl Acad Sci U S A. 2020;117:26382-26388.
    PubMed     Abstract available
    
    
    
63. LI R, Chen B, Zhang T, Ren Z, et al
    Global COVID-19 pandemic demands joint interventions for the suppression of future waves.
    Proc Natl Acad Sci U S A. 2020;117:26151-26157.
    PubMed     Abstract available
    
    
    
64. CHENG MH, Zhang S, Porritt RA, Noval Rivas M, et al
    Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation.
    Proc Natl Acad Sci U S A. 2020;117:25254-25262.
    PubMed     Abstract available
    
    
    
65. ABKARIAN M, Mendez S, Xue N, Yang F, et al
    Speech can produce jet-like transport relevant to asymptomatic spreading of virus.
    Proc Natl Acad Sci U S A. 2020;117:25237-25245.
    PubMed     Abstract available
    
    
    
66. YAM KC, Jackson JC, Barnes CM, Lau J, et al
    The rise of COVID-19 cases is associated with support for world leaders.
    Proc Natl Acad Sci U S A. 2020;117:25429-25433.
    PubMed     Abstract available
    
    
    
67. NETZ RR, Eaton WA
    Physics of virus transmission by speaking droplets.
    Proc Natl Acad Sci U S A. 2020;117:25209-25211.
    PubMed     Abstract available
    
    
    
68. WILDER B, Charpignon M, Killian JA, Ou HC, et al
    Modeling between-population variation in COVID-19 dynamics in Hubei, Lombardy, and New York City.
    Proc Natl Acad Sci U S A. 2020;117:25904-25910.
    PubMed     Abstract available
    
    
    
69. BRETT TS, Rohani P
    Transmission dynamics reveal the impracticality of COVID-19 herd immunity strategies.
    Proc Natl Acad Sci U S A. 2020;117:25897-25903.
    PubMed     Abstract available
    
    
    
70. RAKER EJ, Zacher M, Lowe SR
    Reply to Ng et al.: Not all trauma is the same, but lessons can be drawn from commonalities.
    Proc Natl Acad Sci U S A. 2020;117:25201-25202.
    PubMed    
    
    
    
71. NG QX, Lim DY, Chee KT
    Not all trauma is the same.
    Proc Natl Acad Sci U S A. 2020;117:25200.
    PubMed    
    
    
    
72. HEINDEL DW, Koppolu S, Zhang Y, Kasper B, et al
    Glycomic analysis of host response reveals high mannose as a key mediator of influenza severity.
    Proc Natl Acad Sci U S A. 2020 Oct 12. pii: 2008203117.
    PubMed     Abstract available
    
    
    
73. LOCKHART M, Hill SJ, Merolla J, Romero M, et al
    America's electorate is increasingly polarized along partisan lines about voting by mail during the COVID-19 crisis.
    Proc Natl Acad Sci U S A. 2020;117:24640-24642.
    PubMed     Abstract available
    
    
    
74. HOLLAND KJ, Cortina LM, Magley VJ, Baker AL, et al
    Don't let COVID-19 disrupt campus climate surveys of sexual harassment.
    Proc Natl Acad Sci U S A. 2020;117:24606-24608.
    PubMed    
    
    
    
75. SEGALES J, Puig M, Rodon J, Avila-Nieto C, et al
    Detection of SARS-CoV-2 in a cat owned by a COVID-19-affected patient in Spain.
    Proc Natl Acad Sci U S A. 2020;117:24790-24793.
    PubMed     Abstract available
    
    
    
76. HOLTER JC, Pischke SE, de Boer E, Lind A, et al
    Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients.
    Proc Natl Acad Sci U S A. 2020;117:25018-25025.
    PubMed     Abstract available
    
    
    
77. STEINMAN JB, Lum FM, Ho PP, Kaminski N, et al
    Reduced development of COVID-19 in children reveals molecular checkpoints gating pathogenesis illuminating potential therapeutics.
    Proc Natl Acad Sci U S A. 2020;117:24620-24626.
    PubMed     Abstract available
    
    
    September 2020
78. ARORA VM, Wray CM, O'Glasser AY, Shapiro M, et al
    Using the curriculum vitae to promote gender equity during the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2020;117:24032.
    PubMed    
    
    
    
79. GROSSMAN G, Kim S, Rexer JM, Thirumurthy H, et al
    Political partisanship influences behavioral responses to governors' recommendations for COVID-19 prevention in the United States.
    Proc Natl Acad Sci U S A. 2020;117:24144-24153.
    PubMed     Abstract available
    
    
    
80. THOMAS LJ, Huang P, Yin F, Luo XI, et al
    Spatial heterogeneity can lead to substantial local variations in COVID-19 timing and severity.
    Proc Natl Acad Sci U S A. 2020;117:24180-24187.
    PubMed     Abstract available
    
    
    
81. HABEL JR, Nguyen THO, van de Sandt CE, Juno JA, et al
    Suboptimal SARS-CoV-2-specific CD8(+) T cell response associated with the prominent HLA-A*02:01 phenotype.
    Proc Natl Acad Sci U S A. 2020;117:24384-24391.
    PubMed     Abstract available
    
    
    
82. RABE BA, Cepko C
    SARS-CoV-2 detection using isothermal amplification and a rapid, inexpensive protocol for sample inactivation and purification.
    Proc Natl Acad Sci U S A. 2020;117:24450-24458.
    PubMed     Abstract available
    
    
    
83. KARATAYEV VA, Anand M, Bauch CT
    Local lockdowns outperform global lockdown on the far side of the COVID-19 epidemic curve.
    Proc Natl Acad Sci U S A. 2020;117:24575-24580.
    PubMed     Abstract available
    
    
    
84. LINDESTAM ARLEHAMN CS, Sette A, Peters B
    Lack of evidence for BCG vaccine protection from severe COVID-19.
    Proc Natl Acad Sci U S A. 2020 Sep 29. pii: 2016733117.
    PubMed    
    
    
    
85. PATELLA V, Delfino G, Bruzzese D, Giuliano A, et al
    The bacillus Calmette-Guerin vaccination allows the innate immune system to provide protection from severe COVID-19 infection.
    Proc Natl Acad Sci U S A. 2020 Sep 29. pii: 2015234117.
    PubMed    
    
    
    
86. BARILLAS-MURY C, Escobar LE, Molina-Cruz A
    Reply to Patella et al. and Lindestam Arlehamn et al.: Complex pandemic dynamics and effect of bacillus Calmette-Guerin (BCG) vaccination on COVID-19 prevalence and mortality.
    Proc Natl Acad Sci U S A. 2020 Sep 29. pii: 2017197117.
    PubMed    
    
    
    
87. MALISCH JL, Harris BN, Sherrer SM, Lewis KA, et al
    Reply to Arora et al.: Concerns and considerations about using the CV as an equity tool.
    Proc Natl Acad Sci U S A. 2020;117:24033-24034.
    PubMed    
    
    
    
88. LIONG S, Oseghale O, To EE, Brassington K, et al
    Influenza A virus causes maternal and fetal pathology via innate and adaptive vascular inflammation in mice.
    Proc Natl Acad Sci U S A. 2020 Sep 21. pii: 2006905117.
    PubMed     Abstract available
    
    
    
89. RAUSCH JW, Capoferri AA, Katusiime MG, Patro SC, et al
    Low genetic diversity may be an Achilles heel of SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2020 Sep 21. pii: 2017726117.
    PubMed    
    
    
    
90. GANGULI A, Mostafa A, Berger J, Aydin MY, et al
    Rapid isothermal amplification and portable detection system for SARS-CoV-2.
    Proc Natl Acad Sci U S A. 2020;117:22727-22735.
    PubMed     Abstract available
    
    
    
91. THURNER S, Klimek P, Hanel R
    A network-based explanation of why most COVID-19 infection curves are linear.
    Proc Natl Acad Sci U S A. 2020;117:22684-22689.
    PubMed     Abstract available
    
    
    
92. 
    Correction to Supporting Information for Sun et al., Prevalent Eurasian avian-like H1N1 swine influenza virus with 2009 pandemic viral genes facilitating human infection.
    Proc Natl Acad Sci U S A. 2020 Sep 8. pii: 2017619117.
    PubMed    
    
    
    
93. WRIGLEY-FIELD E
    US racial inequality may be as deadly as COVID-19.
    Proc Natl Acad Sci U S A. 2020;117:21854-21856.
    PubMed     Abstract available
    
    
    
94. DAMAS J, Hughes GM, Keough KC, Painter CA, et al
    Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates.
    Proc Natl Acad Sci U S A. 2020;117:22311-22322.
    PubMed     Abstract available
    
    
    
95. PERKINS TA, Cavany SM, Moore SM, Oidtman RJ, et al
    Estimating unobserved SARS-CoV-2 infections in the United States.
    Proc Natl Acad Sci U S A. 2020;117:22597-22602.
    PubMed     Abstract available
    
    
    
96. KANG S, Tanaka T, Inoue H, Ono C, et al
    IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome.
    Proc Natl Acad Sci U S A. 2020;117:22351-22356.
    PubMed     Abstract available
    
    
    
97. BETSCH C, Korn L, Sprengholz P, Felgendreff L, et al
    Social and behavioral consequences of mask policies during the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2020;117:21851-21853.
    PubMed     Abstract available
    
    
    
98. KIM E, Shepherd ME, Clinton JD
    The effect of big-city news on rural America during the COVID-19 pandemic.
    Proc Natl Acad Sci U S A. 2020;117:22009-22014.
    PubMed     Abstract available
    
    
    
99. LAU MSY, Grenfell B, Thomas M, Bryan M, et al
    Characterizing superspreading events and age-specific infectiousness of SARS-CoV-2 transmission in Georgia, USA.
    Proc Natl Acad Sci U S A. 2020;117:22430-22435.
    PubMed     Abstract available
    
    
    
100. LIU WJ, Li J, Zou R, Pan J, et al
     Dynamic PB2-E627K substitution of influenza H7N9 virus indicates the in vivo genetic tuning and rapid host adaptation.
     Proc Natl Acad Sci U S A. 2020 Sep 1. pii: 2013267117.
     PubMed     Abstract available
     
     
     
101. SEBHATU A, Wennberg K, Arora-Jonsson S, Lindberg SI, et al
     Explaining the homogeneous diffusion of COVID-19 nonpharmaceutical interventions across heterogeneous countries.
     Proc Natl Acad Sci U S A. 2020;117:21201-21208.
     PubMed     Abstract available
     
     
     August 2020
102. DEARLOVE B, Lewitus E, Bai H, Li Y, et al
     A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants.
     Proc Natl Acad Sci U S A. 2020 Aug 31. pii: 2008281117.
     PubMed     Abstract available
     
     
     
103. KANG YL, Chou YY, Rothlauf PW, Liu Z, et al
     Inhibition of PIKfyve kinase prevents infection by Zaire ebolavirus and SARS-CoV-2.
     Proc Natl Acad Sci U S A. 2020;117:20803-20813.
     PubMed     Abstract available
     
     
     
104. SHERIDAN A, Andersen AL, Hansen ET, Johannesen N, et al
     Social distancing laws cause only small losses of economic activity during the COVID-19 pandemic in Scandinavia.
     Proc Natl Acad Sci U S A. 2020;117:20468-20473.
     PubMed     Abstract available
     
     
     
105. GOLDSTEIN JR, Lee RD
     Demographic perspectives on the mortality of COVID-19 and other epidemics.
     Proc Natl Acad Sci U S A. 2020 Aug 20. pii: 2006392117.
     PubMed     Abstract available
     
     
     
106. HOLTZ D, Zhao M, Benzell SG, Cao CY, et al
     Interdependence and the cost of uncoordinated responses to COVID-19.
     Proc Natl Acad Sci U S A. 2020;117:19837-19843.
     PubMed     Abstract available
     
     
     
107. WEILL JA, Stigler M, Deschenes O, Springborn MR, et al
     Social distancing responses to COVID-19 emergency declarations strongly differentiated by income.
     Proc Natl Acad Sci U S A. 2020;117:19658-19660.
     PubMed     Abstract available
     
     
     
108. DUQUE D, Morton DP, Singh B, Du Z, et al
     Timing social distancing to avert unmanageable COVID-19 hospital surges.
     Proc Natl Acad Sci U S A. 2020;117:19873-19878.
     PubMed     Abstract available
     
     
     
109. OMARY MB, Hassan M
     Opinion: Here's how we restore productivity and vigor to the biomedical research workforce in the midst of COVID-19.
     Proc Natl Acad Sci U S A. 2020;117:19612-19614.
     PubMed    
     
     
     
110. SEKIZUKA T, Itokawa K, Kageyama T, Saito S, et al
     Haplotype networks of SARS-CoV-2 infections in the Diamond Princess cruise ship outbreak.
     Proc Natl Acad Sci U S A. 2020;117:20198-20201.
     PubMed     Abstract available
     
     
     
111. VENTER ZS, Aunan K, Chowdhury S, Lelieveld J, et al
     COVID-19 lockdowns cause global air pollution declines.
     Proc Natl Acad Sci U S A. 2020;117:18984-18990.
     PubMed     Abstract available
     
     
     
112. ARPINO B, Bordone V, Pasqualini M
     No clear association emerges between intergenerational relationships and COVID-19 fatality rates from macro-level analyses.
     Proc Natl Acad Sci U S A. 2020;117:19116-19121.
     PubMed     Abstract available
     
     
     
113. CAUCHOIS R, Koubi M, Delarbre D, Manet C, et al
     Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19.
     Proc Natl Acad Sci U S A. 2020;117:18951-18953.
     PubMed     Abstract available
     
     
     
114. HAMER M, Gale CR, Kivimaki M, Batty GD, et al
     Overweight, obesity, and risk of hospitalization for COVID-19: A community-based cohort study of adults in the United Kingdom.
     Proc Natl Acad Sci U S A. 2020 Aug 11. pii: 2011086117.
     PubMed     Abstract available
     
     
     
115. LYCETT SJ, Pohlmann A, Staubach C, Caliendo V, et al
     Genesis and spread of multiple reassortants during the 2016/2017 H5 avian influenza epidemic in Eurasia.
     Proc Natl Acad Sci U S A. 2020 Aug 7. pii: 2001813117.
     PubMed     Abstract available
     
     
     
116. HRABOWSKI FA 3RD, Tracy JK, Henderson PH
     Opinion: At a Crossroads: Reimagining science, engineering, and medicine-and its practitioners.
     Proc Natl Acad Sci U S A. 2020;117:18137-18141.
     PubMed    
     
     
     July 2020
117. BARTIK AW, Bertrand M, Cullen Z, Glaeser EL, et al
     The impact of COVID-19 on small business outcomes and expectations.
     Proc Natl Acad Sci U S A. 2020;117:17656-17666.
     PubMed     Abstract available
     
     
     
118. XIE W, Campbell S, Zhang W
     Working memory capacity predicts individual differences in social-distancing compliance during the COVID-19 pandemic in the United States.
     Proc Natl Acad Sci U S A. 2020;117:17667-17674.
     PubMed     Abstract available
     
     
     
119. VERDERY AM, Smith-Greenaway E, Margolis R, Daw J, et al
     Tracking the reach of COVID-19 kin loss with a bereavement multiplier applied to the United States.
     Proc Natl Acad Sci U S A. 2020;117:17695-17701.
     PubMed     Abstract available
     
     
     
120. MOGHADAS SM, Fitzpatrick MC, Sah P, Pandey A, et al
     The implications of silent transmission for the control of COVID-19 outbreaks.
     Proc Natl Acad Sci U S A. 2020;117:17513-17515.
     PubMed     Abstract available
     
     
     
121. EYAL N, Lipsitch M
     Opinion: It's ethical to test promising coronavirus vaccines against less-promising ones.
     Proc Natl Acad Sci U S A. 2020 Jul 22. pii: 2014154117.
     PubMed    
     
     
     
122. BERTOZZI AL, Franco E, Mohler G, Short MB, et al
     The challenges of modeling and forecasting the spread of COVID-19.
     Proc Natl Acad Sci U S A. 2020;117:16732-16738.
     PubMed     Abstract available
     
     
     
123. YAO Y, Kadam RU, Lee CD, Woehl JL, et al
     An influenza A hemagglutinin small-molecule fusion inhibitor identified by a new high-throughput fluorescence polarization screen.
     Proc Natl Acad Sci U S A. 2020 Jul 20. pii: 2006893117.
     PubMed     Abstract available
     
     
     
124. LIAO HY, Wang SC, Ko YA, Lin KI, et al
     Chimeric hemagglutinin vaccine elicits broadly protective CD4 and CD8 T cell responses against multiple influenza strains and subtypes.
     Proc Natl Acad Sci U S A. 2020 Jul 15. pii: 2004783117.
     PubMed     Abstract available
     
     
     
125. SIEGENFELD AF, Taleb NN, Bar-Yam Y
     Opinion: What models can and cannot tell us about COVID-19.
     Proc Natl Acad Sci U S A. 2020;117:16092-16095.
     PubMed    
     
     
     
126. LAMMERS J, Crusius J, Gast A
     Correcting misperceptions of exponential coronavirus growth increases support for social distancing.
     Proc Natl Acad Sci U S A. 2020;117:16264-16266.
     PubMed     Abstract available
     
     
     
127. ESTEVE A, Permanyer I, Boertien D, Vaupel JW, et al
     National age and coresidence patterns shape COVID-19 vulnerability.
     Proc Natl Acad Sci U S A. 2020;117:16118-16120.
     PubMed     Abstract available
     
     
     
128. IMAI M, Iwatsuki-Horimoto K, Hatta M, Loeber S, et al
     Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development.
     Proc Natl Acad Sci U S A. 2020;117:16587-16595.
     PubMed     Abstract available
     
     
     
129. ELLEBEDY AH, Nachbagauer R, Jackson KJL, Dai YN, et al
     Adjuvanted H5N1 influenza vaccine enhances both cross-reactive memory B cell and strain-specific naive B cell responses in humans.
     Proc Natl Acad Sci U S A. 2020 Jul 13. pii: 1906613117.
     PubMed     Abstract available
     
     
     
130. ESCOBAR LE, Molina-Cruz A, Barillas-Mury C
     BCG vaccine protection from severe coronavirus disease 2019 (COVID-19).
     Proc Natl Acad Sci U S A. 2020 Jul 9. pii: 2008410117.
     PubMed     Abstract available
     
     
     
131. BONACCORSI G, Pierri F, Cinelli M, Flori A, et al
     Economic and social consequences of human mobility restrictions under COVID-19.
     Proc Natl Acad Sci U S A. 2020;117:15530-15535.
     PubMed     Abstract available
     
     
     
132. MALISCH JL, Harris BN, Sherrer SM, Lewis KA, et al
     Opinion: In the wake of COVID-19, academia needs new solutions to ensure gender equity.
     Proc Natl Acad Sci U S A. 2020;117:15378-15381.
     PubMed    
     
     
     
133. TAM VC, Suen R, Treuting PM, Armando A, et al
     PPARalpha exacerbates necroptosis, leading to increased mortality in postinfluenza bacterial superinfection.
     Proc Natl Acad Sci U S A. 2020;117:15789-15798.
     PubMed     Abstract available
     
     
     
134. AREVALO CP, Le Sage V, Bolton MJ, Eilola T, et al
     Original antigenic sin priming of influenza virus hemagglutinin stalk antibodies.
     Proc Natl Acad Sci U S A. 2020 Jul 6. pii: 1920321117.
     PubMed     Abstract available
     
     
     
135. MULLER NF, Stolz U, Dudas G, Stadler T, et al
     Bayesian inference of reassortment networks reveals fitness benefits of reassortment in human influenza viruses.
     Proc Natl Acad Sci U S A. 2020 Jul 6. pii: 1918304117.
     PubMed     Abstract available
     
     
     June 2020
136. ZHANG R, Li Y, Zhang AL, Wang Y, et al
     Identifying airborne transmission as the dominant route for the spread of COVID-19.
     Proc Natl Acad Sci U S A. 2020;117:14857-14863.
     PubMed     Abstract available
     
     
     
137. BENZELL SG, Collis A, Nicolaides C
     Rationing social contact during the COVID-19 pandemic: Transmission risk and social benefits of US locations.
     Proc Natl Acad Sci U S A. 2020;117:14642-14644.
     PubMed     Abstract available
     
     
     
138. SUN H, Xiao Y, Liu J, Wang D, et al
     Prevalent Eurasian avian-like H1N1 swine influenza virus with 2009 pandemic viral genes facilitating human infection.
     Proc Natl Acad Sci U S A. 2020 Jun 29. pii: 1921186117.
     PubMed     Abstract available
     
     
     
139. SCHREIBER A, Boff L, Anhlan D, Krischuns T, et al
     Dissecting the mechanism of signaling-triggered nuclear export of newly synthesized influenza virus ribonucleoprotein complexes.
     Proc Natl Acad Sci U S A. 2020 Jun 29. pii: 2002828117.
     PubMed     Abstract available
     
     
     
140. DOWD JB, Andriano L, Brazel DM, Rotondi V, et al
     Reply to Nepomuceno et al.: A renewed call for detailed social and demographic COVID-19 data from all countries.
     Proc Natl Acad Sci U S A. 2020;117:13884-13885.
     PubMed    
     
     
     
141. NEPOMUCENO MR, Acosta E, Alburez-Gutierrez D, Aburto JM, et al
     Besides population age structure, health and other demographic factors can contribute to understanding the COVID-19 burden.
     Proc Natl Acad Sci U S A. 2020;117:13881-13883.
     PubMed    
     
     
     
142. WANG Y, Liu M, Gao J
     Enhanced receptor binding of SARS-CoV-2 through networks of hydrogen-bonding and hydrophobic interactions.
     Proc Natl Acad Sci U S A. 2020;117:13967-13974.
     PubMed     Abstract available
     
     
     
143. CEBALLOS G, Ehrlich PR, Raven PH
     Vertebrates on the brink as indicators of biological annihilation and the sixth mass extinction.
     Proc Natl Acad Sci U S A. 2020;117:13596-13602.
     PubMed     Abstract available
     
     
     
144. FORSTER P, Forster L, Renfrew C, Forster M, et al
     Reply to Sanchez-Pacheco et al., Chookajorn, and Mavian et al.: Explaining phylogenetic network analysis of SARS-CoV-2 genomes.
     Proc Natl Acad Sci U S A. 2020;117:12524-12525.
     PubMed    
     
     
     
145. RAKER EJ, Zacher M, Lowe SR
     Lessons from Hurricane Katrina for predicting the indirect health consequences of the COVID-19 pandemic.
     Proc Natl Acad Sci U S A. 2020;117:12595-12597.
     PubMed     Abstract available
     
     
     
146. ZENG F, Chen X, Deng G
     Convalescent plasma for patients with COVID-19.
     Proc Natl Acad Sci U S A. 2020;117:12528.
     PubMed    
     
     
     
147. KESICI S, Yavuz S, Bayrakci B
     Get rid of the bad first: Therapeutic plasma exchange with convalescent plasma for severe COVID-19.
     Proc Natl Acad Sci U S A. 2020;117:12526-12527.
     PubMed    
     
     
     
148. DUAN K, Liu B, Li C, Zhang H, et al
     Reply to Kesici et al. and Zeng et al.: Blocking the virus and reducing the inflammatory damage in COVID-19.
     Proc Natl Acad Sci U S A. 2020;117:12529-12530.
     PubMed    
     
     
     
149. CHOOKAJORN T
     Evolving COVID-19 conundrum and its impact.
     Proc Natl Acad Sci U S A. 2020;117:12520-12521.
     PubMed    
     
     
     
150. MAVIAN C, Pond SK, Marini S, Magalis BR, et al
     Sampling bias and incorrect rooting make phylogenetic network tracing of SARS-COV-2 infections unreliable.
     Proc Natl Acad Sci U S A. 2020;117:12522-12523.
     PubMed    
     
     
     
151. SANCHEZ-PACHECO SJ, Kong S, Pulido-Santacruz P, Murphy RW, et al
     Median-joining network analysis of SARS-CoV-2 genomes is neither phylogenetic nor evolutionary.
     Proc Natl Acad Sci U S A. 2020;117:12518-12519.
     PubMed    
     
     
     
152. STADNYTSKYI V, Bax CE, Bax A, Anfinrud P, et al
     The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission.
     Proc Natl Acad Sci U S A. 2020;117:11875-11877.
     PubMed     Abstract available
     
     
     May 2020
153. DELAVERIS CS, Webster ER, Banik SM, Boxer SG, et al
     Membrane-tethered mucin-like polypeptides sterically inhibit binding and slow fusion kinetics of influenza A virus.
     Proc Natl Acad Sci U S A. 2020 May 26. pii: 1921962117.
     PubMed     Abstract available
     
     
     
154. BENTO AI, Nguyen T, Wing C, Lozano-Rojas F, et al
     Evidence from internet search data shows information-seeking responses to news of local COVID-19 cases.
     Proc Natl Acad Sci U S A. 2020;117:11220-11222.
     PubMed     Abstract available
     
     
     
155. REILLY EC, Lambert Emo K, Buckley PM, Reilly NS, et al
     TRM integrins CD103 and CD49a differentially support adherence and motility after resolution of influenza virus infection.
     Proc Natl Acad Sci U S A. 2020 May 21. pii: 1915681117.
     PubMed     Abstract available
     
     
     
156. XU X, Han M, Li T, Sun W, et al
     Effective treatment of severe COVID-19 patients with tocilizumab.
     Proc Natl Acad Sci U S A. 2020;117:10970-10975.
     PubMed     Abstract available
     
     
     
157. MADHUSOODANAN J
     News Feature: To counter the pandemic, clinicians bank on repurposed drugs.
     Proc Natl Acad Sci U S A. 2020;117:10616-10620.
     PubMed    
     
     
     
158. GATTO M, Bertuzzo E, Mari L, Miccoli S, et al
     Spread and dynamics of the COVID-19 epidemic in Italy: Effects of emergency containment measures.
     Proc Natl Acad Sci U S A. 2020;117:10484-10491.
     PubMed     Abstract available
     
     
     
159. DOWD JB, Andriano L, Brazel DM, Rotondi V, et al
     Demographic science aids in understanding the spread and fatality rates of COVID-19.
     Proc Natl Acad Sci U S A. 2020;117:9696-9698.
     PubMed     Abstract available
     
     
     
160. MCDERMOTT A
     Inner Workings: Molecular biologists offer "wartime service" in the effort to test for COVID-19.
     Proc Natl Acad Sci U S A. 2020;117:9656-9659.
     PubMed    
     
     
     April 2020
161. FORSTER P, Forster L, Renfrew C, Forster M, et al
     Phylogenetic network analysis of SARS-CoV-2 genomes.
     Proc Natl Acad Sci U S A. 2020;117:9241-9243.
     PubMed     Abstract available
     
     
     
162. DUAN K, Liu B, Li C, Zhang H, et al
     Effectiveness of convalescent plasma therapy in severe COVID-19 patients.
     Proc Natl Acad Sci U S A. 2020;117:9490-9496.
     PubMed     Abstract available
     
     
     
163. MOGHADAS SM, Shoukat A, Fitzpatrick MC, Wells CR, et al
     Projecting hospital utilization during the COVID-19 outbreaks in the United States.
     Proc Natl Acad Sci U S A. 2020;117:9122-9126.
     PubMed     Abstract available
     
     
     March 2020
164. WELLS CR, Sah P, Moghadas SM, Pandey A, et al
     Impact of international travel and border control measures on the global spread of the novel 2019 coronavirus outbreak.
     Proc Natl Acad Sci U S A. 2020;117:7504-7509.
     PubMed     Abstract available
     
     
     
165. MATSUYAMA S, Nao N, Shirato K, Kawase M, et al
     Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells.
     Proc Natl Acad Sci U S A. 2020;117:7001-7003.
     PubMed     Abstract available
     
     
     
166. PEEPLES L
     News Feature: Avoiding pitfalls in the pursuit of a COVID-19 vaccine.
     Proc Natl Acad Sci U S A. 2020 Mar 30. pii: 2005456117.
     PubMed    
     
     
     
167. JONES JC, Pascua PNQ, Fabrizio TP, Marathe BM, et al
     Influenza A and B viruses with reduced baloxavir susceptibility display attenuated in vitro fitness but retain ferret transmissibility.
     Proc Natl Acad Sci U S A. 2020 Mar 26. pii: 1916825117.
     PubMed     Abstract available
     
     
     
168. DE WIT E, Feldmann F, Cronin J, Jordan R, et al
     Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
     Proc Natl Acad Sci U S A. 2020;117:6771-6776.
     PubMed     Abstract available
     
     
     
169. PABIS A, Rawle RJ, Kasson PM
     Influenza hemagglutinin drives viral entry via two sequential intramembrane mechanisms.
     Proc Natl Acad Sci U S A. 2020 Mar 18. pii: 1914188117.
     PubMed     Abstract available
     
     
     
170. CHO JH, Zhao B, Shi J, Savage N, et al
     Molecular recognition of a host protein by NS1 of pandemic and seasonal influenza A viruses.
     Proc Natl Acad Sci U S A. 2020 Mar 9. pii: 1920582117.
     PubMed     Abstract available
     
     
     
171. MARREIROS R, Muller-Schiffmann A, Trossbach SV, Prikulis I, et al
     Disruption of cellular proteostasis by H1N1 influenza A virus causes alpha-synuclein aggregation.
     Proc Natl Acad Sci U S A. 2020 Mar 9. pii: 1906466117.
     PubMed     Abstract available
     
     
     
172. KLOEPFER KM, Gern JE
     Ecological and individual data both indicate that influenza inhibits rhinovirus infection.
     Proc Natl Acad Sci U S A. 2020 Mar 3. pii: 1922920117.
     PubMed    
     
     
     
173. NICKBAKHSH S, Mair C, Matthews L, Reeve R, et al
     Reply to Kloepfer and Gern: Independent studies suggest an arms race between influenza and rhinovirus: What next?
     Proc Natl Acad Sci U S A. 2020 Mar 3. pii: 2000903117.
     PubMed    
     
     
     
174. YANG Q, Zhao X, Lemey P, Suchard MA, et al
     Assessing the role of live poultry trade in community-structured transmission of avian influenza in China.
     Proc Natl Acad Sci U S A. 2020 Mar 2. pii: 1906954117.
     PubMed     Abstract available
     
     
     February 2020
175. TORABIFARD H, Panahi A, Brooks CL 3rd
     M2 amphipathic helices facilitate pH-dependent conformational transition in influenza A virus.
     Proc Natl Acad Sci U S A. 2020 Feb 3. pii: 1913385117.
     PubMed     Abstract available
     
     
     January 2020
176. NEWMAN JH, Chesson CB, Herzog NL, Bommareddy PK, et al
     Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer.
     Proc Natl Acad Sci U S A. 2020;117:1119-1128.
     PubMed     Abstract available
     
     
     
177. YEH YT, Gulino K, Zhang Y, Sabestien A, et al
     A rapid and label-free platform for virus capture and identification from clinical samples.
     Proc Natl Acad Sci U S A. 2020;117:895-901.
     PubMed     Abstract available
     
     
     
178. COVES-DATSON EM, King SR, Legendre M, Gupta A, et al
     A molecularly engineered antiviral banana lectin inhibits fusion and is efficacious against influenza virus infection in vivo.
     Proc Natl Acad Sci U S A. 2020 Jan 13. pii: 1915152117.
     PubMed     Abstract available
     
     
     December 2019
179. MCCARTHY KR, Raymond DD, Do KT, Schmidt AG, et al
     Affinity maturation in a human humoral response to influenza hemagglutinin.
     Proc Natl Acad Sci U S A. 2019 Dec 16. pii: 1915620116.
     PubMed     Abstract available
     
     
     
180. VIRK RK, Jayakumar J, Mendenhall IH, Moorthy M, et al
     Divergent evolutionary trajectories of influenza B viruses underlie their contemporaneous epidemic activity.
     Proc Natl Acad Sci U S A. 2019 Dec 16. pii: 1916585116.
     PubMed     Abstract available
     
     
     
181. NICKBAKHSH S, Mair C, Matthews L, Reeve R, et al
     Virus-virus interactions impact the population dynamics of influenza and the common cold.
     Proc Natl Acad Sci U S A. 2019 Dec 16. pii: 1911083116.
     PubMed     Abstract available
     
     
     October 2019
182. 
     Correction for Sah et al., Future epidemiological and economic impacts of universal influenza vaccines.
     Proc Natl Acad Sci U S A. 2019 Oct 21. pii: 1917260116.
     PubMed    
     
     
     
183. BRACHER J
     On the multibin logarithmic score used in the FluSight competitions.
     Proc Natl Acad Sci U S A. 2019;116:20809-20810.
     PubMed    
     
     
     
184. REICH NG, Osthus D, Ray EL, Yamana TK, et al
     Reply to Bracher: Scoring probabilistic forecasts to maximize public health interpretability.
     Proc Natl Acad Sci U S A. 2019;116:20811-20812.
     PubMed    
     
     
     
185. POPOVA AV, Safina KR, Ptushenko VV, Stolyarova AV, et al
     Allele-specific nonstationarity in evolution of influenza A virus surface proteins.
     Proc Natl Acad Sci U S A. 2019 Oct 2. pii: 1904246116.
     PubMed     Abstract available
     
     
     September 2019
186. SAH P, Alfaro-Murillo JA, Fitzpatrick MC, Neuzil KM, et al
     Future epidemiological and economic impacts of universal influenza vaccines.
     Proc Natl Acad Sci U S A. 2019 Sep 23. pii: 1909613116.
     PubMed     Abstract available
     
     
     August 2019
187. KENNEY AD, McMichael TM, Imas A, Chesarino NM, et al
     IFITM3 protects the heart during influenza virus infection.
     Proc Natl Acad Sci U S A. 2019 Aug 26. pii: 1900784116.
     PubMed     Abstract available
     
     
     
188. SCHMIDT N, Domingues P, Golebiowski F, Patzina C, et al
     An influenza virus-triggered SUMO switch orchestrates co-opted endogenous retroviruses to stimulate host antiviral immunity.
     Proc Natl Acad Sci U S A. 2019 Aug 7. pii: 1907031116.
     PubMed     Abstract available
     
     
     July 2019
189. WINARSKI KL, Tang J, Klenow L, Lee J, et al
     Antibody-dependent enhancement of influenza disease promoted by increase in hemagglutinin stem flexibility and virus fusion kinetics.
     Proc Natl Acad Sci U S A. 2019 Jul 11. pii: 1821317116.
     PubMed     Abstract available
     
     
     June 2019
190. LITVINOVA M, Liu QH, Kulikov ES, Ajelli M, et al
     Reactive school closure weakens the network of social interactions and reduces the spread of influenza.
     Proc Natl Acad Sci U S A. 2019 Jun 17. pii: 1821298116.
     PubMed     Abstract available
     
     
     May 2019
191. ZHU B, Zhang R, Li C, Jiang L, et al
     BCL6 modulates tissue neutrophil survival and exacerbates pulmonary inflammation following influenza virus infection.
     Proc Natl Acad Sci U S A. 2019 May 28. pii: 1902310116.
     PubMed     Abstract available
     
     
     
192. DE GREEF JC, Slutter B, Anderson ME, Hamlyn R, et al
     Protective role for the N-terminal domain of alpha-dystroglycan in Influenza A virus proliferation.
     Proc Natl Acad Sci U S A. 2019 May 16. pii: 1904493116.
     PubMed     Abstract available
     
     
     
193. KUDO E, Song E, Yockey LJ, Rakib T, et al
     Low ambient humidity impairs barrier function and innate resistance against influenza infection.
     Proc Natl Acad Sci U S A. 2019 May 13. pii: 1902840116.
     PubMed     Abstract available
     
     
     April 2019
194. MASLANKA FIGUEROA S, Veser A, Abstiens K, Fleischmann D, et al
     Influenza A virus mimetic nanoparticles trigger selective cell uptake.
     Proc Natl Acad Sci U S A. 2019 Apr 29. pii: 1902563116.
     PubMed     Abstract available
     
     
     February 2019
195. CULLEN JG, McQuilten HA, Quinn KM, Olshansky M, et al
     CD4(+) T help promotes influenza virus-specific CD8(+) T cell memory by limiting metabolic dysfunction.
     Proc Natl Acad Sci U S A. 2019 Feb 20. pii: 1808849116.
     PubMed     Abstract available
     
     
     
196. TSENG YC, Wu CY, Liu ML, Chen TH, et al
     Egg-based influenza split virus vaccine with monoglycosylation induces cross-strain protection against influenza virus infections.
     Proc Natl Acad Sci U S A. 2019 Feb 19. pii: 1819197116.
     PubMed     Abstract available
     
     
     
197. WHITE MC, Tao H, Steel J, Lowen AC, et al
     H5N8 and H7N9 packaging signals constrain HA reassortment with a seasonal H3N2 influenza A virus.
     Proc Natl Acad Sci U S A. 2019 Feb 13. pii: 1818494116.
     PubMed     Abstract available
     
     
     
198. VIBOUD C, Vespignani A
     The future of influenza forecasts.
     Proc Natl Acad Sci U S A. 2019 Feb 8. pii: 1822167116.
     PubMed    
     
     
     
199. MORIYAMA M, Ichinohe T
     High ambient temperature dampens adaptive immune responses to influenza A virus infection.
     Proc Natl Acad Sci U S A. 2019 Feb 4. pii: 1815029116.
     PubMed     Abstract available
     
     
     January 2019
200. YAMAUCHI Y
     Quantum dots crack the influenza uncoating puzzle.
     Proc Natl Acad Sci U S A. 2019 Jan 31. pii: 1822089116.
     PubMed    
     
     
     
201. REICH NG, Brooks LC, Fox SJ, Kandula S, et al
     A collaborative multiyear, multimodel assessment of seasonal influenza forecasting in the United States.
     Proc Natl Acad Sci U S A. 2019 Jan 15. pii: 1812594116.
     PubMed     Abstract available
     
     
     
202. SEVY AM, Wu NC, Gilchuk IM, Parrish EH, et al
     Multistate design of influenza antibodies improves affinity and breadth against seasonal viruses.
     Proc Natl Acad Sci U S A. 2019 Jan 14. pii: 1806004116.
     PubMed     Abstract available
     
     
     
203. QIN C, Li W, Li Q, Yin W, et al
     Real-time dissection of dynamic uncoating of individual influenza viruses.
     Proc Natl Acad Sci U S A. 2019 Jan 9. pii: 1812632116.
     PubMed     Abstract available
     
     
     December 2018
204. FURUSE Y
     Analysis of research intensity on infectious disease by disease burden reveals which infectious diseases are neglected by researchers.
     Proc Natl Acad Sci U S A. 2018 Dec 31. pii: 1814484116.
     PubMed     Abstract available
     
     
     
205. ZHANG K, Shang G, Padavannil A, Wang J, et al
     Structural-functional interactions of NS1-BP protein with the splicing and mRNA export machineries for viral and host gene expression.
     Proc Natl Acad Sci U S A. 2018;115:E12218-E12227.
     PubMed     Abstract available
     
     
     
206. LUO G, Ambati A, Lin L, Bonvalet M, et al
     Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy.
     Proc Natl Acad Sci U S A. 2018 Dec 12. pii: 1818150116.
     PubMed     Abstract available
     
     
     
207. LIU QH, Ajelli M, Aleta A, Merler S, et al
     Measurability of the epidemic reproduction number in data-driven contact networks.
     Proc Natl Acad Sci U S A. 2018;115:12680-12685.
     PubMed     Abstract available
     
     
     November 2018
208. FINK AL, Engle K, Ursin RL, Tang WY, et al
     Biological sex affects vaccine efficacy and protection against influenza in mice.
     Proc Natl Acad Sci U S A. 2018 Nov 19. pii: 1805268115.
     PubMed     Abstract available
     
     
     
209. STEWART-JONES GBE, Chuang GY, Xu K, Zhou T, et al
     Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1-4.
     Proc Natl Acad Sci U S A. 2018 Nov 12. pii: 1811980115.
     PubMed     Abstract available
     
     
     October 2018
210. GOLDHILL DH, Te Velthuis AJW, Fletcher RA, Langat P, et al
     The mechanism of resistance to favipiravir in influenza.
     Proc Natl Acad Sci U S A. 2018 Oct 23. pii: 1811345115.
     PubMed     Abstract available
     
     
     September 2018
211. BENTON DJ, Nans A, Calder LJ, Turner J, et al
     Influenza hemagglutinin membrane anchor.
     Proc Natl Acad Sci U S A. 2018 Sep 17. pii: 1810927115.
     PubMed     Abstract available
     
     
     
212. SJAASTAD LE, Fay EJ, Fiege JK, Macchietto MG, et al
     Distinct antiviral signatures revealed by the magnitude and round of influenza virus replication in vivo.
     Proc Natl Acad Sci U S A. 2018 Sep 4. pii: 1807516115.
     PubMed     Abstract available
     
     
     August 2018
213. MADSEN JJ, Grime JMA, Rossman JS, Voth GA, et al
     Entropic forces drive clustering and spatial localization of influenza A M2 during viral budding.
     Proc Natl Acad Sci U S A. 2018 Aug 27. pii: 1805443115.
     PubMed     Abstract available
     
     
     
214. LEE JM, Huddleston J, Doud MB, Hooper KA, et al
     Deep mutational scanning of hemagglutinin helps predict evolutionary fates of human H3N2 influenza variants.
     Proc Natl Acad Sci U S A. 2018 Aug 13. pii: 1806133115.
     PubMed     Abstract available
     
     
     July 2018
215. DENG L, Chang TZ, Wang Y, Li S, et al
     Heterosubtypic influenza protection elicited by double-layered polypeptide nanoparticles in mice.
     Proc Natl Acad Sci U S A. 2018 Jul 31. pii: 1805713115.
     PubMed     Abstract available
     
     
     
216. GUALDONI GA, Mayer KA, Kapsch AM, Kreuzberg K, et al
     Rhinovirus induces an anabolic reprogramming in host cell metabolism essential for viral replication.
     Proc Natl Acad Sci U S A. 2018;115:E7158-E7165.
     PubMed     Abstract available
     
     
     
217. LIN X, Noel JK, Wang Q, Ma J, et al
     Atomistic simulations indicate the functional loop-to-coiled-coil transition in influenza hemagglutinin is not downhill.
     Proc Natl Acad Sci U S A. 2018 Jul 16. pii: 1805442115.
     PubMed     Abstract available
     
     
     June 2018
218. UEKI H, Wang IH, Fukuyama S, Katsura H, et al
     In vivo imaging of the pathophysiological changes and neutrophil dynamics in influenza virus-infected mouse lungs.
     Proc Natl Acad Sci U S A. 2018 Jun 25. pii: 1806265115.
     PubMed     Abstract available
     
     
     
219. ZHOU J, Li C, Sachs N, Chiu MC, et al
     Differentiated human airway organoids to assess infectivity of emerging influenza virus.
     Proc Natl Acad Sci U S A. 2018 Jun 11. pii: 1806308115.
     PubMed     Abstract available
     
     
     April 2018
220. SAH P, Medlock J, Fitzpatrick MC, Singer BH, et al
     Optimizing the impact of low-efficacy influenza vaccines.
     Proc Natl Acad Sci U S A. 2018 Apr 30. pii: 1802479115.
     PubMed     Abstract available
     
     
     
221. KADAM RU, Wilson IA
     A small-molecule fragment that emulates binding of receptor and broadly neutralizing antibodies to influenza A hemagglutinin.
     Proc Natl Acad Sci U S A. 2018 Apr 2. pii: 1801999115.
     PubMed     Abstract available
     
     
     February 2018
222. PEI S, Kandula S, Yang W, Shaman J, et al
     Forecasting the spatial transmission of influenza in the United States.
     Proc Natl Acad Sci U S A. 2018 Feb 26. pii: 1708856115.
     PubMed     Abstract available
     
     
     
223. ZHOU J, Wei J, Choy KT, Sia SF, et al
     Defining the sizes of airborne particles that mediate influenza transmission in ferrets.
     Proc Natl Acad Sci U S A. 2018 Feb 20. pii: 1716771115.
     PubMed     Abstract available
     
     
     January 2018
224. YAN J, Grantham M, Pantelic J, Bueno de Mesquita PJ, et al
     Infectious virus in exhaled breath of symptomatic seasonal influenza cases from a college community.
     Proc Natl Acad Sci U S A. 2018 Jan 18. pii: 1716561115.
     PubMed     Abstract available
     
     
     
225. MENACHERY VD, Schafer A, Burnum-Johnson KE, Mitchell HD, et al
     MERS-CoV and H5N1 influenza virus antagonize antigen presentation by altering the epigenetic landscape.
     Proc Natl Acad Sci U S A. 2018 Jan 16. pii: 1706928115.
     PubMed     Abstract available
     
     
     December 2017
226. RAYMOND DD, Bajic G, Ferdman J, Suphaphiphat P, et al
     Conserved epitope on influenza-virus hemagglutinin head defined by a vaccine-induced antibody.
     Proc Natl Acad Sci U S A. 2017 Dec 18. pii: 1715471115.
     PubMed     Abstract available
     
     
     November 2017
227. ELKINS MR, Williams JK, Gelenter MD, Dai P, et al
     Cholesterol-binding site of the influenza M2 protein in lipid bilayers from solid-state NMR.
     Proc Natl Acad Sci U S A. 2017 Nov 20. pii: 201715127.
     PubMed     Abstract available
     
     
     
228. ZOST SJ, Parkhouse K, Gumina ME, Kim K, et al
     Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains.
     Proc Natl Acad Sci U S A. 2017 Nov 6. pii: 201712377.
     PubMed     Abstract available
     
     
     September 2017
229. ZANIN M, Wong SS, Barman S, Kaewborisuth C, et al
     Molecular basis of mammalian transmissibility of avian H1N1 influenza viruses and their pandemic potential.
     Proc Natl Acad Sci U S A. 2017 Sep 5. pii: 201713974.
     PubMed     Abstract available
     
     
     
230. MAAMARY J, Wang TT, Tan GS, Palese P, et al
     Increasing the breadth and potency of response to the seasonal influenza virus vaccine by immune complex immunization.
     Proc Natl Acad Sci U S A. 2017 Sep 5. pii: 201707950.
     PubMed     Abstract available
     
     
     August 2017
231. THOMASTON JL, Woldeyes RA, Nakane T, Yamashita A, et al
     XFEL structures of the influenza M2 proton channel: Room temperature water networks and insights into proton conduction.
     Proc Natl Acad Sci U S A. 2017 Aug 23. pii: 201705624.
     PubMed     Abstract available
     
     
     July 2017
232. NIKOLAIDIS NM, Noel JG, Pitstick LB, Gardner JC, et al
     Mitogenic stimulation accelerates influenza-induced mortality by increasing susceptibility of alveolar type II cells to infection.
     Proc Natl Acad Sci U S A. 2017 Jul 24. pii: 201621172.
     PubMed     Abstract available
     
     
     
233. ASGARI S, Schlapbach LJ, Anchisi S, Hammer C, et al
     Severe viral respiratory infections in children with IFIH1 loss-of-function mutations.
     Proc Natl Acad Sci U S A. 2017 Jul 17. pii: 201704259.
     PubMed     Abstract available
     
     
     
234. BLACKMORE S, Hernandez J, Juda M, Ryder E, et al
     Influenza infection triggers disease in a genetic model of experimental autoimmune encephalomyelitis.
     Proc Natl Acad Sci U S A. 2017 Jul 10. pii: 201620415.
     PubMed     Abstract available
     
     
     May 2017
235. PIZZOLLA A, Wang Z, Groom JR, Kedzierska K, et al
     Nasal-associated lymphoid tissues (NALTs) support the recall but not priming of influenza virus-specific cytotoxic T cells.
     Proc Natl Acad Sci U S A. 2017 May 1. pii: 201620194.
     PubMed     Abstract available
     
     
     April 2017
236. XIE J, Sok D, Wu NC, Zheng T, et al
     Immunochemical engineering of cell surfaces to generate virus resistance.
     Proc Natl Acad Sci U S A. 2017 Apr 10. pii: 201702764.
     PubMed     Abstract available
     
     
     
237. SHANKS GD, Brundage JF
     Variable mortality during the 1918 influenza pandemic in Chicago.
     Proc Natl Acad Sci U S A. 2017 Apr 6. pii: 201701344.
     PubMed    
     
     
     March 2017
238. BASKERVILLE EB, Cobey S
     Does influenza drive absolute humidity?
     Proc Natl Acad Sci U S A. 2017 Mar 15. pii: 201700369.
     PubMed    
     
     
     February 2017
239. KREMENTSOV DN, Case LK, Dienz O, Raza A, et al
     Genetic variation in chromosome Y regulates susceptibility to influenza A virus infection.
     Proc Natl Acad Sci U S A. 2017 Feb 27. pii: 201620889.
     PubMed     Abstract available
     
     
     December 2016
240. WU CY, Lin CW, Tsai TI, Lee CD, et al
     Influenza A surface glycosylation and vaccine design.
     Proc Natl Acad Sci U S A. 2016 Dec 27. pii: 201617174.
     PubMed     Abstract available
     
     
     
241. KADAM RU, Wilson IA
     Structural basis of influenza virus fusion inhibition by the antiviral drug Arbidol.
     Proc Natl Acad Sci U S A. 2016 Dec 21. pii: 201617020.
     PubMed     Abstract available
     
     
     
242. PING J, Lopes TJ, Neumann G, Kawaoka Y, et al
     Development of high-yield influenza B virus vaccine viruses.
     Proc Natl Acad Sci U S A. 2016 Dec 5. pii: 201616530.
     PubMed     Abstract available
     
     
     November 2016
243. CHOWELL G, Viboud C
     Pandemic influenza and socioeconomic disparities: Lessons from 1918 Chicago.
     Proc Natl Acad Sci U S A. 2016;113:13557-13559.
     PubMed    
     
     
     
244. GRANTZ KH, Rane MS, Salje H, Glass GE, et al
     Disparities in influenza mortality and transmission related to sociodemographic factors within Chicago in the pandemic of 1918.
     Proc Natl Acad Sci U S A. 2016 Nov 21. pii: 201612838.
     PubMed     Abstract available
     
     
     
245. BJORNSTAD ON, Viboud C
     Timing and periodicity of influenza epidemics.
     Proc Natl Acad Sci U S A. 2016 Nov 3. pii: 201616052.
     PubMed    
     
     
     October 2016
246. DEYLE ER, Maher MC, Hernandez RD, Basu S, et al
     Global environmental drivers of influenza.
     Proc Natl Acad Sci U S A. 2016 Oct 31. pii: 201607747.
     PubMed     Abstract available
     
     
     
247. YAMIN D, Jones FK, DeVincenzo JP, Gertler S, et al
     Vaccination strategies against respiratory syncytial virus.
     Proc Natl Acad Sci U S A. 2016 Oct 31. pii: 201522597.
     PubMed     Abstract available
     
     
     
248. RAMEY AM, Spackman E, Kim-Torchetti M, DeLiberto TJ, et al
     Weak support for disappearance and restricted emergence/persistence of highly pathogenic influenza A in North American waterfowl.
     Proc Natl Acad Sci U S A. 2016;113:E6551-E6552.
     PubMed    
     
     
     
249. LIANG R, Swanson JM, Madsen JJ, Hong M, et al
     Acid activation mechanism of the influenza A M2 proton channel.
     Proc Natl Acad Sci U S A. 2016 Oct 24. pii: 201615471.
     PubMed     Abstract available
     
     
     
250. MOREIRA EA, Locher S, Kolesnikova L, Bolte H, et al
     Synthetically derived bat influenza A-like viruses reveal a cell type- but not species-specific tropism.
     Proc Natl Acad Sci U S A. 2016 Oct 24. pii: 201608821.
     PubMed     Abstract available
     
     
     
251. HE W, Tan GS, Mullarkey CE, Lee AJ, et al
     Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus.
     Proc Natl Acad Sci U S A. 2016 Oct 3. pii: 201609316.
     PubMed     Abstract available
     
     
     September 2016
252. LEON PE, He W, Mullarkey CE, Bailey MJ, et al
     Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact.
     Proc Natl Acad Sci U S A. 2016 Sep 19. pii: 201613225.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: